Module

Patient Management Strategies for Hard-to-Treat Lymphomas

Source: Patient Management Strategies for Hard-to-Treat Lymphomas

Patient Management Strategies for Hard-to-Treat Lymphomas

Faculty:

Susan Blumel, RN, BSN, OCN

CME CREDIT INFORMATION

Release Date: 12/01/06

Expiration Date: 11/30/07

Registered Nurses: 0.6 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

List various novel approaches to treating mantle cell lymphoma and other hard-to-treat lymphomas
Describe differences in efficacy and safety between various novel agents
Discuss optimal dosing and administration strategies for managing adverse effects of novel agents

Topics covered include:

Page 1

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.